Press Releases and News

November 15 2016

LANCL2: A Novel Therapeutic Target for Influenza

BLACKSBURG, VA. November 15, 2016—The Landos Biopharma, Inc. (LANDOS) team has recently explored the potential of activating lanthionine synthetase C-like 2 (LANCL2) to treat infectious[...]